Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-28 @ 8:21 PM
Study NCT ID:
NCT05816057
Status:
COMPLETED
Last Update Posted:
2024-01-03
First Post:
2023-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus
Sponsor:
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2023-02-20
First Submit QC Date:
None
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-01
Last Update Post Date:
2024-01-03
Last Update Post Date Type:
ACTUAL